VTCN1 and breast cancer: To assess the potential of targeting the USP10/B7‐H4 axis to sensitize breast cancer cells to SG, we conducted coculture assays with MDA‐MB‐468 and HCC70 where B7‐H4 or USP10 was knocked down, followed by SG treatment.